Seres Therapeutics, Inc. (MCRB)
13.96
+0.56
(+4.18%)
USD |
NASDAQ |
Feb 06, 16:00
13.86
-0.10
(-0.72%)
After-Hours: 20:00
Seres Therapeutics SG&A Expense (TTM) : 44.08M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Altimmune, Inc. | 22.68M |
| ACADIA Pharmaceuticals, Inc. | 523.36M |
| Alnylam Pharmaceuticals, Inc. | 1.181B |
| Savara, Inc. | 37.38M |
| BioMarin Pharmaceutical, Inc. | 973.41M |